Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival
Genes · 2024
DOI: 10.3390/genes15050567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Pablo Romero-Morelos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Investigación, Universidad Estatal del Valle de Ecatepec, Ecatepec 55210, Estado de México, Mexico. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Fusion Proteins, bcr-abl. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by the presence of the Philadelphia chromosome, a product of the reciprocal translocation t(9;22)(q34;q11), in the BCR and ABL genes. These rearrangements in both genes lead to the formation of various fusion mRNA products, with preferential expression of b2a2, b3a2, and other BCR::ABL1 mRNA variants, combined with additional chromosomal abnormalities. Notably, the distribution and frequency of different mRNA variants vary in different populations. However, studies concerning this in Mexico are limited, and the results have been inconclusive. This study therefore aimed to determine the distribution of BCR::ABL1 mRNA variants in different clinical phases of CML and their effect on hematological parameters and patient survival. This study included 33 patients, whose demographic, clinical, and molecular data on BCR::ABL1 mRNA variants and hematological parameters were collected to identify potential associations. A total of 84.8% (n = 28) of patients had BCR::ABL1 translocation and increased platelet and basophil counts. The most frequent mRNA variant was b3a2 (64.3%), followed by b2a2 (28.6%) and e1a2 (3.6%). Concerning the clinical phases of CML, 75.8% (n = 25), 21.2% (n = 7), and 3% (n = 1) of patients were in the chronic, blast, and accelerated phases, respectively. Moreover, the b3a2 mRNA variant was more commonly identified in patients in the chronic phase. No correlation was observed between mRNA variant expression and patient survival. However, b2a2 was indicative of patients with longer survival as well as those treated with imatinib or nilotinib. Additionally, platelet count could be a marker of BCR::ABL1 translocation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Investigación, Universidad Estatal del Valle de Ecatepec, Ecatepec 55210, Estado de México, Mexico.
- Departamento de Ciencias Aplicadas al Trabajo, División Ciencias de la Salud, Universidad de Guanajuato, Campus León, León 37670, Guanajuato, Mexico.
- Departamento de Medicina y Nutrición, División Ciencias de la Salud, Universidad de Guanajuato, Campus León, León 37670, Guanajuato, México.
- Unidad de Investigación, Hospital Regional de Alta Especialidad del Bajío, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), León 37544, Guanajuato, Mexico.
ORCID-Profile: Pablo Romero-Morelos, Ana Lilia González-Yebra, Beatríz González-Yebra
Zitieren
APA
Romero-Morelos, P., González-Yebra, A. L., Herrerías-García, A., Ruíz-Velázquez, F. A., Bueno-Rosario, L. J., & González-Yebra, B. (2024). Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival. Genes. https://doi.org/10.3390/genes15050567
Vancouver
Romero-Morelos P, González-Yebra AL, Herrerías-García A, Ruíz-Velázquez FA, Bueno-Rosario LJ, González-Yebra B. Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival. Genes. 2024. doi:10.3390/genes15050567
BibTeX
@article{RomeroMorelos2024,
author = {Romero-Morelos, Pablo and González-Yebra, Ana Lilia and Herrerías-García, Anaid and Ruíz-Velázquez, Francisco Arath and Bueno-Rosario, Luis Jonathan and González-Yebra, Beatríz},
title = {Distribution of BCR::ABL1 Transcripts in the Different Clinical Phases of Chronic Myeloid Leukemia: Effect on Hematological Parameters and Patient Survival},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15050567}
}
EUVIMED